Introduction
Extracorporeal life support (ECLS), also referred to as veno-arterial extracorporeal membrane oxygenation (vaECMO) is increasingly used for urgent hemodynamic stabilization in patients with profound cardiogenic shock (CS) or in cardiac arrest (CA). management made ECLS an increasingly discussed and utilized resuscitation tool in specialized centers. If applied successfully, extracorporeal cardiopulmonary resuscitation (ECPR) provides immediate hemodynamic support, resulting in rapid delivery of oxygen to ischemic tissues. Ongoing support can be provided while a profound acidosis and other metabolic derangements are corrected. 4 ECPR increased return of spontaneous circulation (ROSC), and improved survival with good neurological outcome when compared to conventional CPR in several case series with selected patients. 2, 6 -8 The pathophysiologic consequences of CS, CA and CPR are complex and multifactorial. They include among others increased apoptosis, impaired vasoregulation, activated blood coagulation, extensive inflammatory reaction followed by activation of immunologic pathways, and oxidative stress due to increased reactive oxygen species (ROS) and free radical production. 9 Despite the increased use of ECLS in this field, to our knowledge no study has analyzed the incidence of ECLS related hemolysis, taking into account possible effects of previous CA and CPR on the lysis of red blood cells (RBC). Having observed high levels of plasma free hemoglobin (fHb) after ECPR during routine measurements to detect technical-induced hemolysis on ECLS, we undertook this prospective study to analyse the prevalence of hemolysis in different patient groups supported with ECLS. Furthermore, we tried to delineate a potential relationship to cannula size, metabolic acidosis and outcome.
Methods

Study Design
This is a retrospective analysis on prospectively collected data (Regensburg ECLS Registry, January 2010 -June 2016) from consecutive patients that required ECLS due to acute circulatory failure. This study was approved by Ethics Committee of the University of Regensburg (vote # 106-336-104).
Study Population
The main indication for ECLS is intractable hemodynamic instability with evidence of insufficient organ perfusion despite inotropic and vasopressor support. Institutional ECLS management, indications and limitations have been described by Lunz et al 10 and Schopka et al. 3 previously. Exclusion criteria for the present study were lack of documentation of pre-fHb values, death within 24 hours after ECLS implantation, ECLS support due to inability to wean from cardiopulmonary bypass (post-cardiotomy ECLS), and patient age <18 years. The remaining cases were divided into three groups:
1. patients with CA without ROSC that received ECLS support during ongoing CPR (ECPR) 2. patients with CA and ROSC after conventional CPR, but persisting CS treated with ECLS within 12 hours (ROSC + ECLS) 3. patients without CA but severe CS treated with ECLS (CS + ECLS).
Data collection and analysis
Patients baseline characteristics, ECLS management, daily laboratory findings and blood gas analysis, as well as final patient outcome were collected from the Regensburg ECLS Registry. Levels of fHb were recorded before ECLS (pre-fHb), and then daily until end of therapy. fHb concentration was determined using a commercially available calorimetric assay (C462-0A Catachem, Oxford, Connecticut). Unexplained high values were repeated to exclude a sampling error. Primary endpoint was the prevalence of hemolysis before and during ECLS. Successful weaning from ECLS, which was defined as survival for
longer than 48 h after explantation, and survival to hospital discharge with good neurological outcome (Glasgow Outcome Scale 4 or 5, 11 ) were used as secondary endpoint.
Statistics
Continuous data are presented as median (25th/75th percentile); categorical data are presented as number (percentage). Baseline characteristics of the three groups were compared by using the non-parametric Kruskal-Wallis Test for continuous variables and the chi-squared test for nominal variables. Uni-and multivariable logistic regression models were calculated to identify predictors for the outcomes successful weaning and hospital discharge. Differences over time within each group were calculated by using linear mixed models. Simple linear regression models were calculated to identify predictive variables for fHb values. A p-value of 0.05 is considered the threshold of statistical significance. Analyses were made using SAS 9.3 (SAS Institute, Cary, NC, USA).
Results
Baseline Characteristics of the Study Population
Between January 2010 and June 2016, a total of 413 adult patients received ECLS at our institution. Exclusion criteria were lack of documentation of pre-fHb values (n = 147), death within 24 hours after ECLS implantation (n = 21), post-cardiotomy patients (n = 26), and patient age less than 18 years (n = 4). The remaining 215 patients were subclassified into 110 patients in group 1 (ECPR), 45 patients in group 2 (ROSC + ECLS) and 60 patients in group 3 (CS + ECLS).
The cumulative support time was 1,205 days and the median ECLS time per patient was 4 (2/6) days. Different ECLS systems (Cardiohelp HLS-set, n = 119; PLS-system, n = 53, both Maquet Cardiopulmonary, Rastatt, Germany; Deltastream-system/DP-3, n = 21, Xenios, Heilbronn, Germany; ECC.O5-system, n = 22, LivaNova, London, UK) were applied. Ninety percent of patients were supplied with a 15 or 17 French arterial cannula (Maquet) that was inserted percutaneously in Seldinger technique into the femoral artery, the remainder were placed surgically via Dacron graft onto the subclavian artery or received central cannulation.
The baseline characteristics of all patients and study groups are listed in table 1. At the time of cannulation, all patients from group 1 and 2 were intubated; one fourth of the patients from group 3 were awake and not mechanically ventilated. Arterial blood gas analysis showed that patients in group 1 had highest negative base excess, significantly elevated arterial carbon dioxide tension (PaCO 2 ), lower arterial oxygen tension (PaO 2 ), elevated lactate levels, and lower pH values compared to group 3 (table 1 and supplementary file, table S1). First documented venous oxygen saturation was also lowest in group 1 (group 1, 40 (24/61) %; group 2, 53 (44/65) %; group 3, 49 (35/61) %; p = 0.033). Patients in group 1 initially had lower norepinephrine dosage (group 1 vs group 2, p = 0.013) and higher epinephrine dosage (group 1 vs group 2, p = 0.027; group 1 vs group 3, p = 0.006) ( 
Estimation of Red Blood Cell Damage during CPR
The extent of RBC destruction before ECLS implantation was determined by measuring pre-fHb levels. As depicted in Figure 1 , pre-fHb levels from patients of groups 1 and 2 were considerably higher compared to patients without previous resuscitation (group 3 
Effect of ECLS on RBC damage and metabolic acidosis
Within a support time on ECLS of 24 hours, fHb levels decreased markedly for patients who had required CPR previously (groups 1 and 2) ( Figure 3A) . Levels of fHb in group 3, which were lower at onset, did not increase on ECLS. On day 1, median levels of fHb of all groups were comparable and remained unchanged up to the end of therapy ( Figure 3A) . Circulatory support with ECLS resulted in normalization of acid-base disturbances after CA (Figures 3B, 3C) . Within 24 hours, pH values in each group normalized (each p < 0.001). Clearance of accumulated lactate on average required one day in group 1 (p < 0.001) and two days in groups 2 (p = 0.001) and 3 (p = 0.004) ( Figure 3C) . During the further course, median pH values and lactate remained stable.
During ECLS, the amount of blood products supplemented per day was not different between study groups. On average, in all patients 0.39 (0.00/1.00) RBC concentrates per day on ECLS were transfused. Time on ECLS was significantly lower in group 1 (p = 0.001, Table 2 ).
fHb, pH value and lactate as biomarkers for outcome
In a secondary analysis we investigated, whether fHb, pH value and lactate before ECLS could serve as a predictor for outcome. The percentage of patients discharged from hospital was 44%, 53% and 47% for group 1, 2 and 3, respectively (p = 0.547). Successful weaning from ECLS had been achieved in 56%, 73% and Figure 1 Comparison of plasma free hemoglobin, pH and lactate in patient groups before ECLS. group 1: patients with cardiac arrest without return of spontaneous circulation that received ECLS support during ongoing cardio-pulmonary resuscitation (ECPR); group 2: patients with cardiac arrest and return of spontaneous circulation after conventional cardio-pulmonary resuscitation, but persisting cardiogenic shock treated with ECLS within 12 hours (ROSC + ECLS) group 3: patients without cardiac arrest but severe cardiogenic shock treated with ECLS (CS + ECLS) 73% of patients (p = 0.034). Patients, who ever experienced a fHb ≥ 500 mg/L (n = 73) had a mortality rate of 55 %, whereas those, who never were above 499 mg/dL (n = 142), died in 53 %. Comparing survivors (n = 100) and non-survivors (n = 115), median peak level of fHb was 279 (106/651) mg/L versus 326 (152/621) mg/L, respectively (p = 0.358). Logistic regression analyses ( Figure 4 ) demonstrated that independent of the study group high pre-fHb levels were associated with less successful weaning (p = 0.024), but not with discharge from hospital (p = 0.118). A better prognostic value for weaning and discharge was shown for low pH values (p = 0.004 and 0.006, respectively) and high lactate (p < 0.001 and p < 0.001, respectively 
Discussion
The current study reports for the first time on the prevalence of hemolysis in a large cohort of patients supported with ECLS. A surprising finding of our analysis was, that prolonged CPR independently was associated with significant hemolysis documented by a marked increase in fHb before ECLS. The implantation of ECLS did not aggravate hemolysis in addition, but restoration of circulation resulted in reduced RBC damage and control of metabolic disturbances. We could not demonstrate that the degree of pre-fHb is a surrogate marker for successful weaning or discharge from hospital. Only a low pre-lactate level was an independent predictor for successful discharge from hospital. Extracorporeal support of the circulation with restoration of tissue supply reduced hemolysis and controlled metabolic disturbances. Within one day on ECLS, the concentration of fHb decreased significantly. This effect was documented in all patients with high pre-fHb levels. Patients with CS (group 3) and lower levels of fHb displayed no increase in fHb after implantation of ECLS. While the extent of hemolysis decreased sharply during the first days of ECLS and remained low on average, it slowly increased again on day 4 and 5 in a few patients, which may be technically-induced. Hemolysis has been regarded as a common complication of mechanical circulatory support 12 . Hemolysis in ECLS circuits can occur due to a variety of reasons. Erythrocytes tolerate high positive pressures well, however, sudden excessive negative pressures can cause significant hemolysis. Excessive negative pressures are difficult to record and may often be overseen. Most commonly they can appear in hypovolemic states with pumps run at high speed; in practice chattering of venous lines may be seen 13 . We have demonstrated previously, that deliberate Figure 3 Time-course of plasma free hemoglobin (fHb), pH and lactate before ECLS, on day 1 and day 2 during ECLS and at the end of ECLS treatment. group 1: patients with cardiac arrest without return of spontaneous circulation that received ECLS support during ongoing cardio-pulmonary resuscitation (ECPR); group 2: patients with cardiac arrest and return of spontaneous circulation after conventional cardio-pulmonary resuscitation, but persisting cardiogenic shock treated with ECLS within 12 hours (ROSC + ECLS) group 3: patients without cardiac arrest but severe cardiogenic shock treated with ECLS (CS + ECLS) Significance: (A) fHb pre -day1: (group 1, p = <0.0001 group 2, p = 0.0093). (B, C) ECLS support regulated acid-base disturbances after CA. Within 1 day on ECLS, pH value from each group normalized (p < 0.0001). Elimination of accumulated lactate required one day in group 1 (p < 0.001), and two days in group 2 (p = 0.0011) and 3 (p = 0.0041). Statistics: * comparing pre-data with day 1; § comparing pre-data with day 2; # comparing data from day 1 with day 2.
ECLS management with modern technical equipment, sufficiently sized cannulas, limited pump speed and blood flow rates below 4.5 L/min minimizes the risk of mechanical blood trauma in venovenous ECLS 14 . While roller pumps potentially caused significant amounts of hemolysis 15 , the new generation of centrifugal pumps produce at normal clincal use only low levels of hemolysis. 16 We have reported before that markedly increased fHb levels during ECLS support can indicate pump head thrombosis that requires immediate exchange. 17 This was observed again in four patients in . To our knowledge this is the first study demonstrating that patients after prolonged CA and CPR develop significant hemolysis. The underlying mechanisms are unknown. It can be assumed that chest compression during CPR may induce a mechanical trauma to RBCs. Intravascular hemolysis due to mechanical trauma has been shown previously in distance running athletes. 18, 19 In some studies it was shown that electrolyte changes, increased plasma osmolarity and viscosity due to dehydration and acidosis may promote RBC damage after exhausting exercise. 20 Severe metabolic acidemia with median serum pH values below 7.20 is commonly seen in patients after CA 21 and was also documented in our cohort. However, low pH value can not be used as the only explanation for hemolysis. It is known from in-vitro experiments, that RBCs are quite resistant to acidosis and acid-induced hemolysis started to occur at pH levels below 6.0. 22 In our cohort the extent of hemolysis did not correlate with low pH value or increased lactate levels.
CPR after CA is a global ischemia-reperfusion syndrome that causes a cascade of metabolic and electrolyte disturbances 23 , and produces high amounts of ROS. 24 Free radicals, which are increased after resuscitation, can directly damage RBC membranes by peroxidation of membrane polyunsaturated fatty acids. 25 It is likely, that several of the above mentioned mechanisms can affect the integrity and membrane stability of erythrocytes and result in hemolysis. Two potentially important consequences for clinical practice should be mentioned: first, due to high baseline values, the detection of ECLS-induced hemolysis can be hampered in patients post resuscitation. Second, the measuring method for neuron specific enolase (NSE) can be falsified by high levels of fHb. Thus, if NSE is used as a marker for neurological damage post resuscitation, hemolysis may result in wrongly elevated results, rendering prediction of neurological recovery unreliable. 26 -28 Longer duration of CPR aggravated the distruction of RBC in this study. Still, the degree of fHb before ECLS was not a surrogate marker for successful weaning from ECLS or discharge from hospital. Solely low pre-lactate was an independent predictor for successful discharge from hospital, which is in accordance with previous findings. Haas et al screened 14,040 ICU patients (overall ICU mortality 9.8%) for hyperlactatemia and found that severe hyperlactatemia of >10 mmol/l (=90 mg/dL) was associated with a high ICU mortality of 78.2%. 29 In our study group of 215 patients, 81 had a lactate before ECLS ≥ 90 mg/dL, of those 67 % died. Jung et al analyzed 117 patients with ECPR and showed in an multivariant analysis that baseline serum lactate was the strongest predictor of outcome. 30 This study has several limitations, which among others are due to the retrospective analysis of collected data and the relatively small number of patients. It is conceivable that with a larger cohort of patients a predictive value of Hb for survival may be demonstrable, as fHb increased with duration of CRP. In general, the prediction of successful weaning from ECLS and hospital discharge is difficult, as the outcome of patients on ECLS depends on multiple factors. Succ wean., successful weaning; given are median (q1/q3) or absolute (relative) numbers. group 1: patients with cardiac arrest without return of spontaneous circulation that received ECLS support during ongoing cardio-pulmonary resuscitation (ECPR); group 2: patients with cardiac arrest and return of spontaneous circulation after conventional cardio-pulmonary resuscitation, but persisting cardiogenic shock treated with ECLS within 12 hours (ROSC + ECLS); group 3: patients without cardiac arrest but severe cardiogenic shock treated with ECLS (CS + ECLS).
Figure 4
Univariat analysis of plasma free hemoglobin (fHb), pH and lactate before ECLS as predictors for successful weaning and discharge from hospital.
In addition, this study represents data from one institution and as such may mirror a specific clinical management not necessarily transferable to others. It has to be borne in mind that patients with undocumented fHb values as well as patients who died within 24 hours were excluded a priori; these patients possibly would have exhibited the worst damage to organs and RBCs. As documented, RBC damage in this cohort of critically ill patients occurs for many reasons. Thus, to clearly identify hemolysis, which is caused by the ECLS device is nearly impossible.
Conclusions
CA and CPR was associated with hemolysis due to a probably multifactorial damage of RBCs in many patients. Emergency application of ECLS did not further aggravate hemolysis but resulted in a decrease of fHb within 24 hours of circulatory support. Lower lactate levels before ECLS were a prognostic marker for successful weaning from ECLS and hospital discharge. 
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